BioAdaptivesBDPT 9-Day RSI is 36.06 as of Jul. 01, 2026. The stock has 5 warning signs investors should review. Among 2,102 Consumer Packaged Goods companies, BioAdaptives ranks better than 72.41% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-01), BioAdaptives's 9-Day RSI is 36.06.
The industry rank for BioAdaptives's 9-Day RSI or its related term are showing as below:
BDPT's 9-Day RSI is ranked better than 72.41% of 2102
companies
in the Consumer Packaged Goods industry
Industry Median: 45.58
vs BDPT: 36.06
BioAdaptives (OTCPK:BDPT) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
BioAdaptives 9-Day RSI Related Terms
BDPT vs NBND, BSFC, MEHA: 9-Day RSI Comparison
For the Packaged Foods subindustry, BioAdaptives's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioAdaptives 9-Day RSI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where BioAdaptives's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioAdaptives (BDPT) has a 9-Day RSI of 36.06 as of Jul. 01, 2026. According to the industry distribution chart, BioAdaptives ranks #580 out of 2102 companies in the Consumer Packaged Goods industry, placing it in the top 27.6%.
Is BioAdaptives' 9-Day RSI too high?
BioAdaptives' current 9-Day RSI is 36.06. The Consumer Packaged Goods industry median 9-Day RSI is 45.58. BioAdaptives' value of 36.06 is 20.9% below this industry median. Based on the distribution chart, BioAdaptives ranks #580 out of 2102 companies in the Consumer Packaged Goods industry, which is above the industry midpoint.
How does BioAdaptives' 9-Day RSI compare to NBND and BSFC?
According to the Consumer Packaged Goods industry distribution chart, BioAdaptives ranks #580 out of 2102 companies for 9-Day RSI. This puts BioAdaptives in the upper half of its industry. The industry median 9-Day RSI is 45.58. BioAdaptives' value of 36.06 is 20.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Consumer Packaged Goods company?
The median 9-Day RSI among Consumer Packaged Goods companies is 45.58, based on 2,102 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioAdaptives's current 9-Day RSI of 36.06 is 20.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median 9-Day RSI is 45.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioAdaptives's current 9-Day RSI is 36.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioAdaptives stock overvalued right now?
BioAdaptives (BDPT) has a current 9-Day RSI of 36.06. The current 9-Day RSI is 36.06 and 20.9% below the Consumer Packaged Goods industry median of 45.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For BioAdaptives (BDPT), the current 9-Day RSI is 36.06 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDPT has been successfully added to your